Ita-as, Dante U.
HRN: 26-51-57 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/23/2025
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
01/23/2025
01/30/2025
IV
4.5
Q8
Sepsis
Waiting Final Action
Indication: Empiric Type of Infection: PneumoniaBone & JointSkin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes